Physician profile
Jeffrey H Lee
NPI 1467550665
$44,720.37
in general payments reported to CMS, 2019-2025
15 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2021: $1,773 · 2022: $15K · 2023: $4,280 · 2024: $95.52 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,250 · Food and Beverage: $1,341 · Travel and Lodging: $91.37 · Education: $61.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,250.00 |
| Food and Beverage | $1,341.25 |
| Travel and Lodging | $91.37 |
| Education | $61.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $29,340.11 | 2019-2023 | Resolution 360 Clip |
| Olympus America INC. | $13,563.66 | 2019-2022 | |
| Fujifilm Healthcare Americas Corporation | $690.16 | 2023-2025 | Fujifilm |
| Pentax of America, INC. | $284.96 | 2022-2023 | N/A |
| Astellas Pharma US INC | $255.99 | 2022-2023 | |
| Micro-Tech Endoscopy USA, INC. | $135.73 | 2025 | Eyemax |
| Ethicon US, LLC | $116.81 | 2023 | Echelon Flex, Echelon Endopath |
| Conmed Corporation | $90.25 | 2023-2024 | Conmed Dilation, Conmed Hemostasis, Conmed Generators |
| Medtronic, INC. | $57.31 | 2024-2025 | Nexpowder, Endoflip |
| Lumendi LLC | $51.61 | 2019 | |
| Olympus Corporation of The Americas | $36.58 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.92 | 2024-2025 | Xifaxan, Trulance |
| Collegium Pharmaceutical, INC. | $24.79 | 2025 | Belbuca |
| Erbe USA INC | $19.67 | 2021 | |
| Sanofi Pasteur INC. | $18.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.